Want to join the conversation?
$CMCSA 2Q15 Q&A: Hodulik of UBS needs a clarification on has there been a change in marketing your approach to focus more on doubles than triples. Steve replied that we did shift to more double plays than triple plays. If you look at broadband for the 1H15, it's right on what we did in 1H14. We don't think there's any big macro change in approach.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?